drugset / Trial / NCT03830684

A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever

NCT03830684 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study in order to evaluate the Baicalein Tablets' safety and efficiency for audit with influenza

Timeline

Start
2019-02-01
Primary completion
2019-05-31
Completion
2019-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Baicalein Small molecule 400 mg —
Subject Baicalein Small molecule 600 mg —

Indications